ID24897A - Makrolida kristalin - Google Patents

Makrolida kristalin

Info

Publication number
ID24897A
ID24897A IDW991682A ID991682A ID24897A ID 24897 A ID24897 A ID 24897A ID W991682 A IDW991682 A ID W991682A ID 991682 A ID991682 A ID 991682A ID 24897 A ID24897 A ID 24897A
Authority
ID
Indonesia
Prior art keywords
formula
compound
crystaline
macrolides
conditions
Prior art date
Application number
IDW991682A
Other languages
English (en)
Inventor
Cornelia Dosenbach
Maximilian Grassberger
Otto Hartmann
Amarylla Horvath
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10815103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID24897(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID24897A publication Critical patent/ID24897A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Metallurgy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IDW991682A 1997-06-30 1998-06-26 Makrolida kristalin ID24897A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9713730.1A GB9713730D0 (en) 1997-06-30 1997-06-30 Organic compounds

Publications (1)

Publication Number Publication Date
ID24897A true ID24897A (id) 2000-08-31

Family

ID=10815103

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991682A ID24897A (id) 1997-06-30 1998-06-26 Makrolida kristalin

Country Status (32)

Country Link
US (1) US6423722B1 (id)
EP (1) EP0994880B1 (id)
JP (2) JP3880634B2 (id)
KR (1) KR100399765B1 (id)
CN (1) CN1139595C (id)
AR (1) AR017754A1 (id)
AT (1) ATE287410T1 (id)
AU (1) AU739211B2 (id)
BR (1) BR9810956A (id)
CA (1) CA2290412C (id)
CO (1) CO4940463A1 (id)
CZ (1) CZ297244B6 (id)
DE (1) DE69828692T2 (id)
DK (1) DK0994880T3 (id)
ES (1) ES2236922T3 (id)
GB (1) GB9713730D0 (id)
HK (1) HK1028597A1 (id)
HU (1) HU227755B1 (id)
ID (1) ID24897A (id)
IL (1) IL132761A0 (id)
MY (1) MY118718A (id)
NO (1) NO312765B1 (id)
NZ (1) NZ500994A (id)
PE (1) PE97699A1 (id)
PL (1) PL192761B1 (id)
PT (1) PT994880E (id)
RU (1) RU2219181C2 (id)
SK (1) SK285665B6 (id)
TR (1) TR199903189T2 (id)
TW (1) TW552264B (id)
WO (1) WO1999001458A1 (id)
ZA (1) ZA985655B (id)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9713730D0 (en) * 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
GB0125443D0 (en) * 2001-10-23 2001-12-12 Novartis Ag Organic Compounds
EP1663220B1 (en) * 2003-09-03 2009-12-02 Glaxo Group Limited Novel process for the preparation of pleuromutilin derivatives
TWI315310B (en) * 2004-12-01 2009-10-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Methods of preparing pimecrolimus
CA2668134A1 (en) * 2006-11-06 2008-05-15 Teva Gyogyszergyar Zartkoerueen Muekoedoe Reszvenytarsasag Ascomycin and pimecrolimus having reduced levels of des-methylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof
US20100105724A1 (en) * 2006-12-07 2010-04-29 Helsinn Healthcare Sa Crystalline and amorphous forms of palonosetron hydrochloride
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
ES2550634T3 (es) 2009-07-10 2015-11-11 Boston Scientific Scimed, Inc. Uso de nanocristales para un balón de suministro de fármaco
WO2011008393A2 (en) 2009-07-17 2011-01-20 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density
WO2012031236A1 (en) 2010-09-02 2012-03-08 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
WO2013022458A1 (en) * 2011-08-05 2013-02-14 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
US9056152B2 (en) 2011-08-25 2015-06-16 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
WO2014145780A1 (en) 2013-03-15 2014-09-18 Biosensors International Group, Ltd. Purification of rapamycin derivatives
EP3178824A1 (en) 2015-12-08 2017-06-14 Medichem, S.A. Process for preparing pimecrolimus
ES2906158T3 (es) * 2017-05-01 2022-04-13 Meda Pharma Gmbh & Co Kg Proceso para convertir ascomicina bruta en pimecrolimus purificado
EP3741367A1 (en) 2019-05-21 2020-11-25 Premark Pharma GmbH Treatment of ocular disease

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127647A (en) * 1975-04-08 1978-11-28 Meiji Seika Kaisha, Ltd. Process for preparation of stable amorphous macrolide antibiotic solids
JPS51118816A (en) * 1975-04-08 1976-10-19 Meiji Seika Kaisha Ltd A process for stabilizing non-crystalloidal solid
CY1306A (en) 1980-10-01 1985-12-06 Glaxo Group Ltd Aminoalkyl furan derivative
JP2728482B2 (ja) * 1989-01-26 1998-03-18 協和醗酵工業株式会社 マクロライド系抗生物質の精製法
EP0433428B1 (en) 1989-07-10 1994-10-12 Chemferm V.O.F. A stable form of cephradine, process for its production and intermediates used therein
DE69021833T2 (de) * 1989-11-09 1996-03-21 Sandoz Ag Heteroatome enthaltende tricyclische Verbindungen.
WO1991013889A1 (en) * 1990-03-13 1991-09-19 Fisons Plc Immunosuppressive macrocyclic compounds
EP0480623A1 (en) * 1990-10-11 1992-04-15 Merck & Co. Inc. New halomacrolides and derivatives having immunosuppressive activity
US5143918A (en) * 1990-10-11 1992-09-01 Merck & Co., Inc. Halomacrolides and derivatives having immunosuppressive activity
ES2100291T3 (es) 1991-07-30 1997-06-16 Ajinomoto Kk Cristales de n-(trans-4-isopropilciclohexilcarbonil)-d-fenilalanina y metodos para prepararlos.
US5247076A (en) 1991-09-09 1993-09-21 Merck & Co., Inc. Imidazolidyl macrolides having immunosuppressive activity
US5221740A (en) 1992-01-16 1993-06-22 American Home Products Corporation Oxepane isomers of rapamycin useful as immunosuppressive agents
UA41884C2 (uk) * 1993-11-05 2001-10-15 Амерікан Хоум Продактс Корпорейшн Спосіб відокремлення рапаміцину від кислотних, основних та неполярних нейтральних домішок, присутніх в концентраті екстрактів ферментаційного бульйону або маточних розчинів
JP3808500B2 (ja) * 1994-02-22 2006-08-09 キューレータズ オブ ディ ユニバーシティ オブ ミズーリ 分離剤としての大環状抗生物質
WO1997008182A1 (en) * 1995-08-24 1997-03-06 Merck & Co., Inc. Process for the preparation of imidazolyl macrolide immunosuppressants
GB9713730D0 (en) * 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds

Also Published As

Publication number Publication date
CZ474099A3 (cs) 2000-04-12
AU8540998A (en) 1999-01-25
EP0994880A1 (en) 2000-04-26
HUP0003053A3 (en) 2003-03-28
SK186699A3 (en) 2000-05-16
HUP0003053A2 (hu) 2001-02-28
ZA985655B (en) 1998-12-30
EP0994880B1 (en) 2005-01-19
GB9713730D0 (en) 1997-09-03
HK1028597A1 (en) 2001-02-23
TR199903189T2 (xx) 2000-06-21
MY118718A (en) 2005-01-31
KR100399765B1 (ko) 2003-09-29
AU739211B2 (en) 2001-10-04
BR9810956A (pt) 2000-09-26
CA2290412A1 (en) 1999-01-14
PL192761B1 (pl) 2006-12-29
NZ500994A (en) 2001-08-31
CZ297244B6 (cs) 2006-10-11
JP2001506279A (ja) 2001-05-15
RU2219181C2 (ru) 2003-12-20
NO995909L (no) 1999-12-02
TW552264B (en) 2003-09-11
ES2236922T3 (es) 2005-07-16
SK285665B6 (sk) 2007-05-03
CN1139595C (zh) 2004-02-25
PT994880E (pt) 2005-06-30
WO1999001458A1 (en) 1999-01-14
JP4504323B2 (ja) 2010-07-14
DE69828692D1 (de) 2005-02-24
NO312765B1 (no) 2002-07-01
NO995909D0 (no) 1999-12-02
HU227755B1 (en) 2012-02-28
ATE287410T1 (de) 2005-02-15
IL132761A0 (en) 2001-03-19
PE97699A1 (es) 1999-10-29
KR20010020423A (ko) 2001-03-15
CN1261365A (zh) 2000-07-26
JP3880634B2 (ja) 2007-02-14
CA2290412C (en) 2009-11-10
DE69828692T2 (de) 2006-01-12
US6423722B1 (en) 2002-07-23
CO4940463A1 (es) 2000-07-24
AR017754A1 (es) 2001-10-24
PL336719A1 (en) 2000-07-03
DK0994880T3 (da) 2005-05-30
JP2006151999A (ja) 2006-06-15

Similar Documents

Publication Publication Date Title
ID24897A (id) Makrolida kristalin
ES2157254T3 (es) Ceftiofur (acido libre) cristalino.
NO881933L (no) Orale administreringsformer med forsinket avgivning.
BR0015836A (pt) Cristal de 4-carboxiamino-2-etil-1,2,3,4-tetra-hidroquinolina como inibidor de cetp
NO965516L (no) Sterolderivater anvendt til regulering av meiose
NO179867C (no) Sulfonamido- og sulfonamidokarbonyl-pyridin-2-karboksylsyreamider og anvendelse av forbindelsene som legemidler
AR015418A1 (es) Procedimiento para la preparacion de la forma cristalina (modificacion 1) de la n-(trifluormetil-fenil)-5-metil-isoxazol-4-carboxamida.
BR9807326A (pt) Processo para preparar cristais de ácido dicarboxìlico a partir de uma solução contendo pelo menos um ácido dicarboxìlixo orgânico, cristais de ácido dicarboxìlico, e, uso de pelo menos um polieletrólito aniÈnico.
RU2000101826A (ru) Кристаллические макролиды и способ их получения
EP0947507A4 (en) TETRAHYDROBENZINDOLON DERIVATIVES
BR9815862A (pt) Processo para preparação de zeólito l cristalino
BG104712A (en) S-substituted 11beta-benzaldoxime-estra-4,9-diene-carbonic acid thiolesters, method for the production thereof and pharmaceutical preparations containing these compounds
BR9812453A (pt) Cristalização de açúcares
ATE171943T1 (de) Piperidin-verbindungen, ihre darstellung und ihre verwendung
ATE236929T1 (de) Transformierenden waeckstumsfaktor beta krystalle
BR9811855A (pt) Processo para preparação de ácido l-ascórbico
KR970001332A (ko) 피리미딘화합물, 액정조성물 및 액정소자
ECSP982561A (es) Macrolidas cristalinas
BRPI0017522B8 (pt) processo para preparação de secretagogos de hormônio de crescimento e polimorfo
TR199901363T2 (xx) Bir tetrahidro piridin t�revinin kristalle�tirilmesi i�in y�ntem ve bu �ekilde elde edilen kristal �ekiller.
BR0000901A (pt) Derivados 4-fenil-4-heteroarilpiperidina
DE69608012D1 (de) Flüssigkristallines Alkenylcyclohexenderivat, Flüssigkristallzusammensetzung und Flüssigkristallanzeigeelement
DK333986A (da) Fremgangsmaade til modifikation af krystalgittersammensaetningen af etuorganisk, poraest, krystallinsk mineral
ATE26571T1 (de) Kristallisierung von polyaluminium-hydroxidkomplexen.
WO2001030759A3 (en) Sodium-hydrogen exchanger type 1 inhibitor crystals